Logo

American Heart Association

  23
  0


Final ID: MP962

Right heart dimensions and pulmonary arterial wedge pressure in pulmonary arterial hypertension: exploring a controversial relationship

Abstract Body (Do not enter title and authors here): Introduction:Pulmonary capillary wedge pressure (PCWP) provides an indirect estimate of left ventricular (LV) end-diastolic pressure.Its assessment is crucial in evaluating pulmonary hypertension.
Hypothesis:Recent research indicates a correlation between advanced pulmonary arterial hypertension (PAH) and worsened pulmonary congestion, suggesting a paradoxical relationship between right ventricular (RV) dysfunction and elevated lung water content. However, the correlation between PCWP and cardiac chamber size or RV afterload remains unclear in PAH.
Aim:This study aims to evaluate the correlation between PCWP, right and left ventricular dimensions, and right ventricular overload, in a large, multicenter cohort of patients with PAH.
Methods:A post-hoc analysis was conducted from 401 idiopathic, heritable, or PAH associated with connective tissue disease patients, prospectively included in the ULTRAsound RIGHt venTricular eVALUation (ULTRA RIGHT VALUE) registry. This is the first multicentre, observational registry, involving 8 European expert referral PAH centers, characterized by centralized echocardiography reading with high-quality data imaging, according to FDA/EMA regulatory standards. Each patient received a comprehensive clinical, echocardiographic, and hemodynamic evaluation. All echocardiographic images were electronically transmitted to a core laboratory at Sapienza University of Rome for standardized evaluation. Echocardiographic studies were performed on average 0±31 days from RHC. Correlations between PCWP and ventricular dimensions were assessed using Pearson’s correlation coefficient (r).
Results:From January 2022 to December 2023, the study included 401 patients with prevalent PAH. The mean age was 52±17 years. The majority of patients were female (275 patients,68%), with idiopathic PAH (244 patients,61%). One hundred thirty (32.4%) of patients had at least one cardiometabolic comorbidity. Two hundred eighty-nine (72%) patients completed echocardiographic studies within 24 hours after RHC. No significant correlations were observed between PCWP and RV end-diastolic area (r=0.07;p=ns), LV end-diastolic index (r=-0.06;p=ns), and LV end-diastolic area (r=-0.004;p=ns) at baseline. Additionally, no correlation was found between delta PCWP and delta PVR (r=-0.06;p=ns) in 150 patients (37%) from baseline to follow-up.
Conclusion: Increased PVR and echocardiographic data of cardiac chamber size from patients with PAH were not associated with increased PCWP
  • Papa, Silvia  ( Sapienza University of Rome , Rome , Italy )
  • Vizza, Carmine Dario  ( Sapienza University of Rome , Rome , Italy )
  • Benza, Raymond  ( Mount Sinai Heart , No New York , New York , United States )
  • Badagliacca, Roberto  ( Sapienza University of Rome , Rome , Italy )
  • Adamo, Francesca Ileana  ( Sapienza University of Rome , Rome , Italy )
  • Serino, Giorgia  ( Sapienza University of Rome , Rome , Italy )
  • Mihai, Alexandra  ( Sapienza University of Rome , Rome , Italy )
  • Filomena, Domenico  ( Sapienza University of Rome , Rome , Italy )
  • Maggio, Enrico  ( Sapienza University of Rome , Rome , Italy )
  • Scoccia, Gianmarco  ( Sapienza University of Rome , Rome , Italy )
  • Manzi, Giovanna  ( Sapienza University of Rome , Rome , Italy )
  • Author Disclosures:
    Silvia Papa: DO NOT have relevant financial relationships | Carmine Dario Vizza: No Answer | Raymond Benza: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):united therapeutics :Active (exists now) ; Other (please indicate in the box next to the company name):abbott:Active (exists now) ; Other (please indicate in the box next to the company name):gossamer:Active (exists now) ; Other (please indicate in the box next to the company name):cereno:Active (exists now) | roberto badagliacca: No Answer | Francesca Ileana Adamo: No Answer | Giorgia Serino: No Answer | Alexandra Mihai: DO NOT have relevant financial relationships | Domenico Filomena: No Answer | Enrico Maggio: No Answer | Gianmarco Scoccia: No Answer | Giovanna Manzi: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Visualizing Pulmonary Hypertension: Exploring the Role of Imaging in Disease Understanding

Saturday, 11/08/2025 , 01:45PM - 03:00PM

Moderated Digital Poster Session

More abstracts on this topic:
Can Noninvasive Evaluation of Right Atrial Pressure by Internal Jugular Vein Imaging Complement Inferior Vena Cava Imaging?

Murugesan Lakshmi, Htay Yan Naung, Kasi Sakthi, Manova Angelena, Prabhakaran Shakthi, Victor Varun, Gopalakrishnan Prabhakaran

A Multicenter Study of Detection of Pulmonary Hypertension Based on Point-of-Care 12- Lead ECG Data

Dubrock Hilary, Wieczorek Mikolaj, Hackett Sarah, Alger Heather, Carlson Katherine, Klugherz Paul, Carter Rickey, Wagner Tyler, Johnson Patrick, Frantz Robert, Strom Jordan, Waks Jonathan, Agarwal Richa, Hemnes Anna, Steinberg Benjamin, Pandey Ambarish

More abstracts from these authors:
Orthotopic Heart Transplant in a Patient with Chronic Lymphocytic Leukemia: Challenges in Management

Radakrishnan Ankitha, Sharma Apurva, Oloomi Mehdi, Trivieri Maria Giovanna, Love Barry, Benza Raymond

My Patient Has PAH: How Do I Risk Stratify?

Benza Raymond, Frantz Robert, Weatherald Jason

You have to be authorized to contact abstract author. Please, Login
Not Available